Juan Xing

Juan Xing

Auto-generated profile, based on publicly available information

Juan Xing

Department of Pathology, Cleveland Clinic, Cleveland, Ohio

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2017 in Cancer Cytopathology
Verified
Journal Article
Closed access
PDF file
MHMatthew G. Hanna
Matthew G. Hanna
SMSara E. Monaco
Sara E. Monaco
JCJacqueline Cuda
Jacqueline Cuda
JXJuan Xing
Juan Xing
IAIshtiaque Ahmed
Ishtiaque Ahmed
LPLiron Pantanowitz
Liron Pantanowitz

14 April 2022 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
JXJuan Xing
Juan Xing
YLYiqun Liao
Yiqun Liao
HZhuan zhang
huan zhang
WZWenjie Zhang
Wenjie Zhang
ZZZhilin Zhang
Zhilin Zhang
Dong TangDong Tang
Dong Tang
Although a dysfunctional gut microbiome is strongly linked to colorectal cancer (CRC), our knowledge of the mediators between CRC and the microbiome is limited. MicroRNAs (miRNAs) affect critical cellular processes, such as apoptosis, proliferation, and differentiation, and contribute to the regulation of CRC progression. Increasingly, studies found that miRNAs can significantly mediate bidirectional interactions between the host and the microbiome. Notably, miRNA expression is regulated by the gut microbiome, which subsequently affects the host transcriptome, thereby influencing the development of CRC. This study typically focuses on the specific functions of the microbiome in CRC and their effect on CRC-related miRNA production and reviews the role of several bacteria on miRNA, including Fusobacterium nucleatum, Escherichia coli, enterotoxigenic Bacteroides fragilis, and Faecalibacterium prausnitzii. Based on the important roles of miRNAs and the gut microbiome in CRC, strategies for modulating miRNA expression and regulating the gut microbiome composition need to be applied, such as bioactive dietary components and fecal microorganism transplantation.

25 July 2018 in Journal of the American Society of Cytopathology
Verified
Journal Article
Closed access
JXJuan Xing
Juan Xing
SMSara E. Monaco
Sara E. Monaco
LPLiron Pantanowitz
Liron Pantanowitz

26 January 2020 in Cytopathology
Verified
Journal Article
Closed access
PDF file
JXJuan Xing
Juan Xing
SMSara E. Monaco
Sara E. Monaco
JCJacqueline Cuda
Jacqueline Cuda
LPLiron Pantanowitz
Liron Pantanowitz

2 May 2018 in Cancer Cytopathology
Verified
Journal Article
Closed access
PDF file
JMJulia L. Manzo
Julia L. Manzo
JCJackie Cuda
Jackie Cuda
LPLiron Pantanowitz
Liron Pantanowitz
JXJuan Xing
Juan Xing
JYJing Yu
Jing Yu
SMSara E. Monaco
Sara E. Monaco

1 August 2015 in Acta Cytologica
Verified
Journal Article
Closed access
JXJuan Xing
Juan Xing
LRLisa Radkay
Lisa Radkay
SMSara E. Monaco
Sara E. Monaco
CRChristine G. Roth
Christine G. Roth
LPLiron Pantanowitz
Liron Pantanowitz
Lyme disease can affect the central nervous system causing a B-cell-predominant lymphocytic pleocytosis. Since most reactions to infection in the cerebrospinal fluid (CSF) are typically T-cell predominant, a B-cell-predominant lymphocytosis raises concern for lymphoma. We present 3 Lyme neuroborreliosis cases in order to illustrate the challenging cytomorphological and immunophenotypic features of their CSF specimens. Three male patients who presented with central nervous system manifestations were diagnosed with Lyme disease. The clinical presentation, laboratory tests, CSF cytological examination and flow-cytometric studies were described for each case. CSF cytology showed lymphocytic pleocytosis with increased plasmacytoid cells and/or plasma cells. Flow cytometry showed the presence of polytypic B lymphocytes with evidence of plasmacytic differentiation in 2 cases. In all cases, Lyme disease was confirmed by the Lyme screening test and Western blotting. In such cases of Lyme neuroborreliosis, flow cytometry of CSF samples employing plasmacytic markers and cytoplasmic light-chain analysis is diagnostically helpful to exclude lymphoma.